Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 12;12(10):967.
doi: 10.3390/metabo12100967.

The Beneficial Effects of Bariatric-Surgery-Induced Weight Loss on Renal Function

Affiliations
Review

The Beneficial Effects of Bariatric-Surgery-Induced Weight Loss on Renal Function

Diego Moriconi et al. Metabolites. .

Abstract

Obesity represents an independent risk factor for the development of chronic kidney disease (CKD), leading to specific histopathological alterations, known as obesity-related glomerulopathy. Bariatric surgery is the most effective means of inducing and maintaining sustained weight loss. Furthermore, in the context of bariatric-surgery-induced weight loss, a reduction in the proinflammatory state and an improvement in the adipokine profile occur, which may also contribute to the improvement of renal function following bariatric surgery. However, the assessment of renal function in the context of obesity and following marked weight loss is difficult, since the formulas adopted to estimate glomerular function use biomarkers whose production is dependent on muscle mass (creatinine) or adipose tissue mass and inflammation (cystatin-c). Thus, following bariatric surgery, the extent to which reductions in plasma concentrations reflect the actual improvement in renal function is not clear. Despite this limitation, the available literature suggests that in patients with hyperfiltration at baseline, GFR is reduced following bariatric surgery, whereas GFR is increased in patients with decreased GFR at baseline. These findings are also confirmed in the few studies that have used measured rather than estimated GFR. Albuminuria is also decreased following bariatric surgery. Moreover, bariatric surgery seems superior in achieving the remission of albuminuria and early CKD than the best medical treatment. In this article, we discuss the pathophysiology of renal complications in obesity, review the mechanisms through which weight loss induces improvements in renal function, and provide an overview of the renal outcomes following bariatric surgery.

Keywords: bariatric surgery; obesity; renal function; renal metabolism; renal perfusion; renal sinus fat.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Following bariatric-surgery-induced weight loss, visceral adipose tissue deposits are decreased, as well as renal sinus fat deposits. The decrease in the former contributes to a favorable adipocytokine profile, reduction in inflammatory cytokines, and reduction in ROS production, while the latter might lead to a less-activated RAAS. Decreased total renal blood flow has also been described following bariatric-surgery-induced weight loss. Clinically, following bariatric surgery, the glomerular filtration rate is decreased in patients with glomerular hyperfiltration and increased in patients who already have a more advanced stage of chronic kidney disease. In both stages, albuminuria is decreased. These favorable outcomes ultimately decrease the rate of progression towards a more advanced stage of chronic kidney disease.

References

    1. Moriconi D., Manca M.L., Anselmino M., Rebelos E., Bellini R., Taddei S., Ferrannini E., Nannipieri M. Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study. Diabetes Metab. 2021;48:101282. doi: 10.1016/j.diabet.2021.101282. - DOI - PubMed
    1. Wilhelm S., Young J., Kale-Pradhan P. Effect of bariatric surgery on hypertension: A meta-analysis. Ann. Pharm. 2014;48:674–682. doi: 10.1177/1060028014529260. - DOI - PubMed
    1. Haroun M.K., Jaar B., Hoffman S.C., Comstock G.W., Klag M.J., Coresh J. Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J. Am. Soc. Nephrol. 2003;14:2934–2941. doi: 10.1097/01.ASN.0000095249.99803.85. - DOI - PubMed
    1. Wang Y., Chen X., Song Y., Caballero B., Cheskin L.J. Association between obesity and kidney disease: A systematic review and meta-analysis. Kidney Int. 2008;73:19–33. doi: 10.1038/sj.ki.5002586. - DOI - PubMed
    1. De Nicola L., Cozzolino M., Genovesi S., Gesualdo L., Grandaliano G., Pontremoli R. Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease? J. Nephrol. 2022;35:1605–1618. doi: 10.1007/s40620-022-01336-7. - DOI - PMC - PubMed

LinkOut - more resources